Australia markets close in 4 hours 40 minutes

RAPT Therapeutics, Inc. (RAPT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.0800-0.1600 (-4.94%)
At close: 04:00PM EDT
3.2000 +0.12 (+3.90%)
After hours: 07:57PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 106.80M
Enterprise value -28.45M
Trailing P/E 0.77
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)411.22
Price/book (mrq)0.82
Enterprise value/revenue 677.37
Enterprise value/EBITDA -10.73

Trading information

Stock price history

Beta (5Y monthly) 0.40
52-week change 3-83.99%
S&P500 52-week change 324.43%
52-week high 327.3500
52-week low 32.9900
50-day moving average 35.5114
200-day moving average 313.4891

Share statistics

Avg vol (3-month) 3785.34k
Avg vol (10-day) 3485.74k
Shares outstanding 534.9M
Implied shares outstanding 634.9M
Float 831.55M
% held by insiders 11.85%
% held by institutions 194.09%
Shares short (15 May 2024) 43.11M
Short ratio (15 May 2024) 43.16
Short % of float (15 May 2024) 411.98%
Short % of shares outstanding (15 May 2024) 48.92%
Shares short (prior month 15 Apr 2024) 43.18M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-39.60%
Return on equity (ttm)-67.20%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -126.79M
Net income avi to common (ttm)-118.05M
Diluted EPS (ttm)-3.0800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)141.58M
Total cash per share (mrq)4.06
Total debt (mrq)6.32M
Total debt/equity (mrq)4.83%
Current ratio (mrq)7.01
Book value per share (mrq)3.76

Cash flow statement

Operating cash flow (ttm)-105.53M
Levered free cash flow (ttm)-65.35M